Sensus Healthcare, Inc. (SRTS) Income Statement Analysis

See more : PT Bali Bintang Sejahtera Tbk (BOLA.JK) Income Statement Analysis – Financial Results

Complete financial analysis of Sensus Healthcare, Inc. (SRTS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Sensus Healthcare, Inc., a leading company in the Medical – Devices industry within the Healthcare sector.

You may be interested

InterCloud Systems, Inc. (ICLD) Income Statement Analysis – Financial Results
Shanghai Sinyang Semiconductor Materials Co., Ltd. (300236.SZ) Income Statement Analysis – Financial Results
Eurotex Industries and Exports Limited (EUROTEXIND.BO) Income Statement Analysis – Financial Results
Twitter, Inc. (delisted) (TWTR) Income Statement Analysis – Financial Results
Kaveri Seed Company Limited (KSCL.NS) Income Statement Analysis – Financial Results

Sensus Healthcare, Inc. (SRTS)

Industry: Medical - Devices

Sector: Healthcare

Website: https://www.sensushealthcare.com

About Sensus Healthcare, Inc.

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a SRT-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and in-office laser rental services. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.

Metric	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Revenue	24.41M	44.53M	27.04M	9.58M	27.26M	26.43M	20.59M	14.81M	10.27M	5.81M	10.48M
Cost of Revenue	10.35M	14.90M	10.05M	4.33M	9.71M	9.52M	6.79M	4.97M	3.70M	2.05M	3.60M
Gross Profit	14.06M	29.63M	16.99M	5.25M	17.56M	16.91M	13.80M	9.85M	6.57M	3.76M	6.88M
Gross Profit Ratio	57.61%	66.53%	62.82%	54.81%	64.40%	63.99%	67.03%	66.48%	64.00%	64.63%	65.64%
Research & Development	3.68M	3.46M	3.44M	4.16M	6.42M	6.26M	5.49M	1.82M	1.47M	1.58M	1.33M
General & Administrative	5.16M	5.01M	4.59M	3.99M	4.00M	4.12M	3.72M	3.47M	1.59M	1.65M	1.45M
Selling & Marketing	5.61M	6.33M	4.84M	5.34M	9.10M	8.53M	8.31M	4.92M	3.74M	4.21M	3.97M
SG&A	10.76M	11.34M	9.43M	9.33M	13.11M	12.66M	12.03M	8.38M	5.33M	5.86M	5.42M
Other Expenses	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Expenses	14.44M	14.80M	12.87M	13.48M	19.53M	18.92M	17.52M	10.21M	6.80M	7.44M	6.75M
Cost & Expenses	24.79M	29.70M	22.92M	17.81M	29.23M	28.43M	24.31M	15.17M	10.49M	9.49M	10.35M
Interest Income	992.00K	382.00K	2.00K	52.56K	268.29K	139.28K	75.81K	38.54K	1.78K	820.00	1.25K
Interest Expense	0.00	2.00K	1.00K	14.23K	0.00	156.69K	68.88K	21.87K	17.79K	20.03K	20.47K
Depreciation & Amortization	461.00K	315.00K	613.00K	721.87K	545.72K	658.26K	387.92K	337.58K	315.60K	272.65K	265.56K
EBITDA	79.00K	14.83M	4.73M	-6.10M	-1.15M	-1.21M	-3.25M	13.00K	96.12K	-3.41M	393.65K
EBITDA Ratio	0.32%	34.16%	15.24%	-100.03%	-6.24%	-7.06%	-17.69%	-2.19%	0.94%	-58.63%	3.76%
Operating Income	-382.00K	14.83M	4.12M	-8.23M	-1.97M	-2.01M	-3.72M	-363.12K	-221.26K	-3.68M	126.84K
Operating Income Ratio	-1.57%	33.30%	15.24%	-85.98%	-7.22%	-7.59%	-18.06%	-2.45%	-2.15%	-63.34%	1.21%
Total Other Income/Expenses	1.03M	13.16M	-1.00K	1.40M	268.29K	-17.41K	6.93K	16.67K	-16.01K	-19.21K	-19.21K
Income Before Tax	652.00K	27.99M	4.12M	-6.84M	-1.70M	-2.02M	-3.71M	-346.45K	-237.27K	-3.70M	107.63K
Income Before Tax Ratio	2.67%	62.85%	15.23%	-71.37%	-6.24%	-7.65%	-18.02%	-2.34%	-2.31%	-63.67%	1.03%
Income Tax Expense	167.00K	3.75M	-613.00K	-2.12M	-545.72K	139.28K	-312.11K	-299.05K	1.78K	820.00	1.25K
Net Income	485.00K	24.24M	4.12M	-4.72M	-1.15M	-2.02M	-3.71M	-346.45K	-237.27K	-3.70M	107.63K
Net Income Ratio	1.99%	54.44%	15.23%	-49.24%	-4.23%	-7.65%	-18.02%	-2.34%	-2.31%	-63.67%	1.03%
EPS	0.03	1.47	0.25	-0.29	-0.07	-0.14	-0.28	-0.03	-0.02	-0.37	-0.04
EPS Diluted	0.03	1.46	0.25	-0.29	-0.07	-0.14	-0.28	-0.03	-0.02	-0.37	-0.04
Weighted Avg Shares Out	16.26M	16.48M	16.48M	16.43M	16.23M	14.12M	13.24M	12.03M	10.78M	9.88M	9.79M
Weighted Avg Shares Out (Dil)	16.27M	16.62M	16.50M	16.43M	16.23M	14.12M	13.24M	12.03M	10.78M	9.89M	9.89M

Wall Street Analysts Think Sensus Healthcare (SRTS) Is a Good Investment: Is It?

August 29, 2024zacks.com

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

Sensus Healthcare: Recurring Revenue Initiatives Are Exciting

August 25, 2024seekingalpha.com

Sensus Healthcare offers equipment for skin problems, with strong demand but vulnerable to economic instability. The company is recovering in 2024, with initiatives for recurring revenue to improve income stability through software and maintenance services. It has begun its expansion...

Is Sensus Healthcare (SRTS) Outperforming Other Medical Stocks This Year?

August 14, 2024zacks.com

Here is how Sensus Healthcare, Inc. (SRTS) and Amneal Pharmaceuticals (AMRX) have performed compared to their sector so far this year.

Sensus Healthcare, Inc. (SRTS) Recently Broke Out Above the 20-Day Moving Average

August 14, 2024zacks.com

From a technical perspective, Sensus Healthcare, Inc. (SRTS) is looking like an interesting pick, as it just reached a key level of support. SRTS recently overtook the 20-day moving average, and this suggests a short-term bullish trend.

Sensus Healthcare (SRTS) is on the Move, Here's Why the Trend Could be Sustainable

August 14, 2024zacks.com

Sensus Healthcare (SRTS) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

Best Momentum Stocks to Buy for August 13th

August 13, 2024zacks.com

BLBD and SRTS made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 13, 2024.

Wall Street Analysts Believe Sensus Healthcare (SRTS) Could Rally 64.74%: Here's is How to Trade

August 13, 2024zacks.com

The consensus price target hints at a 64.7% upside potential for Sensus Healthcare (SRTS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an...